Mr. Speaker, this is not a problem of disclosure. This is a problem of conflict of interest. The minister's personal monetary interests are ahead of the interests of Canadians.
Since having shares in a pharmaceutical company is preventing the minister from introducing a national strategy on pharmaceutical products, why is he keeping his shares in the company?
Is it because he knows that the aim of a national strategy would be to provide medications at the lowest possible cost and this would make him lose money?